Design, synthesis and pharmacological profile of novel dopamine D2 receptor ligands

…, A El-Nabawi, AT Eldefrawi, EX Albuquerque…

Index: Menegatti, Ricardo; Cunha, Anna C.; Ferreira, Vitor F.; Perreira, Edna F. R.; El-Nabawi, Ahmed; Eldefrawi, Amira T.; Albuquerque, Edson X.; Neves, Gilda; Rates, Stela M. K.; Fraga, Carlos A. M.; Barreiro, Eliezer J. Bioorganic and Medicinal Chemistry, 2003 , vol. 11, # 22 p. 4807 - 4813

Full Text: HTML

Citation Number: 70

Abstract

The present study describes the synthesis and pharmacological profile of three novel heterocyclic compounds originally designed, on the basis of bioisosterism, as dopamine D2 receptor ligands: 1-[1-(4-chlorophenyl)-1H-pyrazol-4-ylmethyl]-4-phenyl-piperazine (LASSBio-579), 1-phenyl-4-(1-phenyl-1H-[1, 2, 3] triazol-4-ylmethyl)-piperazine (LASSBio- 580) and 1-[1-(4-chlorophenyl)-1H-[1, 2, 3] triazol-4-ylmethyl]-4-phenyl-piperazine ( ...

Related Articles:

Experimental and theoretical investigation of optical nonlinearities in (nitrovinyl)-1H-pyrazole derivative

[Dwivedi; De Boni; Goncalves; Mairink; Menegatti; Fonseca; Zilio Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2013 , vol. 105, p. 483 - 487]

Design, synthesis and pharmacological profile of novel dopamine D2 receptor ligands

[Bioorganic and Medicinal Chemistry, , vol. 11, # 22 p. 4807 - 4813]

Complete assignment of NMR data of 22 phenyl??1H??pyrazoles' derivatives

[Magnetic Resonance in Chemistry, , vol. 49, # 8 p. 537 - 542]

More Articles...